Has Mladen Djurasovic, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,093,123 in general payments to Mladen Djurasovic, MD across 392 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mladen Djurasovic, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mladen Djurasovic, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mladen Djurasovic, MD

Orthopaedic Surgery of the Spine · Louisville, KYNPI 1609839257

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,893,332 of the $3,093,123 with a category attached, or 93.5%. Medtronic accounts for 64.6% of it on its own, with 13 other manufacturers making up the rest. Among orthopaedic surgery of the spine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,093,123in general payments, 2019–2025

Across 392 payments — averaging $7890.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2M
Globus Medical$1.1M
Stryker$18K
Expanding Innovations, Inc.$10K
Alphatec Spine, Inc$273
Curiteva, Inc.$245
plus $1K from 8 others

$34,515in research payments, 2019–2025

Across 14 payments — averaging $2465.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$27K
Cerapedics Inc.$6K
Medtronic$950

$10,200in ownership & investment interests, 2019–2025

Across 1 payment — averaging $10,200 each. An ownership or investment interest held by the physician or an immediate family member.

Expanding Innovations, Inc.$10K

What the payments were for

Royalty or licence$2,893,33294%
Consulting fees$98,1953%
Speaking & faculty fees$68,5702%
Travel & lodging$22,8521%
Food & beverage$9,8150%
Education$3590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	284	$1,999,163
Globus Medical(2 entities)	70	$1,064,173
Stryker	14	$17,937
Expanding Innovations, Inc.	1	$10,200
Alphatec Spine, Inc	2	$273
Curiteva, Inc.	1	$245
Spinal Elements, Inc.	1	$185
Providence Medical Technology, Inc.	2	$157
EBI, LLC	1	$146
4web, Inc.	1	$137
Cerapedics Inc.	12	$130
Si-bone, Inc.	1	$128
Medacta USA, Inc.	1	$125
Orthofix Medical, Inc.	1	$124

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Modulus$1,053,850
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$347,914
ALIF$125,302
TLIF$109,501
CD HORIZON$57,766
CD HORIZON SPINAL SYSTEM$32,089
CANYON RETRACTOR SYSTEMS$16,250
CASCADIA INTERBODY SYSTEM$16,250
X-PAC$10,200
ELEVATE$10,080
ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$5,122
XLIF$2,734
EVEREST SPINAL SYSTEM$1,555
ExcelsiusGPS Robotic Navigation System$832
MAZOR X SYSTEM$601
UNID_PASS$561
Pulse$333
iGA$237
LIF$175
Sable$174

How this compares

$3,093,123 in reported general payments places this provider in the 95th percentile of 29 orthopaedic surgery of the spine providers in Kentucky.

See all orthopaedic surgery of the spine providers in Kentucky →

Medicare billing

Part B allowed, 2024

$236,217

Medicare patients

234

Services billed

972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Baclofen	54	$733
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	32	$480
Tizanidine Hcl	63	$423
Gabapentin	40	$269
Tramadol Hcl	36	$192
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$182
Methylprednisolone	21	$128
Cyclobenzaprine Hcl	40	$116
Meloxicam	57	$111
Methocarbamol	12	$99
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Louisville

Jeffery GumLouisville$3.5M
Roger OwensLouisville$1.3M
Charles CrawfordLouisville$836K
Joseph LarattaLouisville$819K
Venu VemuriLouisville$796K
Kathryn McCarthy MulloolyLouisville$426K
John DimarLouisville$266K
Steven GlassmanLouisville$249K
John JohnsonLouisville$247K
Mitchell CampbellLouisville$212K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →